NANOBIOTIX Announces Presentation of First Data From Phase 1

NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer

NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Texas , United States , Paris , France General , France , New York , Cambridge , Cambridgeshire , United Kingdom , Massachusetts , American , Pierre Louis Germain , Brandon Owens , Ligia Vela Reid , Drug Administration , University Of Texas Md Anderson Cancer Center , Linkedin , American Association For Cancer Research , Communications Department , French Financial Markets Authority Autorit , Nasdaq , Exchange Commission , Johnson , Twitter , Investor Relations Department , Euronext , Given The Company , First Data From Phase , Patients With Locally Advanced Pancreatic , Pancreatic Cancer , American Association , Cancer Center , Cancer Research , Endoscopic Ultrasound Guided , Locally Advanced , Borderline Resectable Pancreatic Cancer , Overall Survival , United States Food , Fast Track , Greater China , Asian Markets , Janssen Pharmaceutica , Euronext Paris , Nasdaq Global Select Market , New York City , Private Securities Litigation Reform Act , Annual Report , French Financial Markets Authority , Des March ,